Charles Schwab Investment Management Inc. Boosts Stock Position in Cytek Biosciences, Inc. (NASDAQ:CTKB)
Charles Schwab Investment Management Inc. grew its stake in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 3.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,062,990 shares of the company’s stock after buying an additional 32,028 […]
Charles Schwab Investment Management Inc. grew its stake in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 3.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,062,990 shares of the company’s stock after buying an additional 32,028 […]
